
Strange News: Big Pharma, Mysterious Airport Moans and Bret Favre
Stuff They Don't Want You To Know
00:00
Biogen Paid 900 Million Dollars for Multiple Sclerosis Drugs
The lawsuit stems from a whistleblower who alleged that biogen was improperly influencing healthcare professionals into prescribing their medications specifically for multiple sclerosis. According to this person's complaint between 2009 and 2014, they offered and paid renumeration in the form of speaker honor area. The suit is saying that biogen improperly uses money to influence these people and they paid $900 million for it.
Play episode from 31:00
Transcript


